Cresco Labs secures up to $200 million in debt for marijuana operations

Cresco Labs, a multistate cannabis operator based in Chicago, said it has secured up to $200 million in debt funding from a syndicate of lenders.

The money is earmarked to:

• Expand operations in Illinois, where it’s based.
• Finance pending acquisitions
• Fund other growth initiatives.

The company expects to draw down up to an initial $100 million of the total by the end of January.

The remaining maximum of $100 million will be a mutually agreed-upon figure with the lenders.

The debt financing was secured with a number of investors, including institutional lenders as well as members of the management team at Cresco and its board.

The interest rate for the initial amount of up to $100 million is roughly 12.7% to 13.2%, depending on payback terms.

While capital is in short supply in the marijuana industry, Cresco’s deal shows that well-run cannabis companies can still access money.

Cresco’s move follows that of another multistate operator, Massachusetts-based Curaleaf, which last weekclosed up to a $300 million debt offering.

Cresco trades on the Canadian Securities Exchange asCL.

– Nick Thomas

For analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward,sign upfor our premium subscription service,Investor Intelligence.

Pure CBD Hemp Oil

• Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

• Clinically proven therapeutic effects.

• Relieves anxiety and stress

• Eliminates chronic pain and aches

• Regulates mood and sleep patterns

• Enhances focus and clarity
  
  
  

George Scorsis Liberty Health Sciences
Originally posted on Cresco Labs secures up to $200 million in debt for marijuana operations via Cannabis Industry News